177 related articles for article (PubMed ID: 16611153)
1. Plasminogen activator system and vascular disease.
Nicholl SM; Roztocil E; Davies MG
Curr Vasc Pharmacol; 2006 Apr; 4(2):101-16. PubMed ID: 16611153
[TBL] [Abstract][Full Text] [Related]
2. The expression of plasminogen activator system in a rat model of periodontal wound healing.
Xiao Y; Li H; Bunn C; Bartold PM
J Periodontol; 2001 Jul; 72(7):849-57. PubMed ID: 11495131
[TBL] [Abstract][Full Text] [Related]
3. Three decades of research on plasminogen activator inhibitor-1: a multifaceted serpin.
Declerck PJ; Gils A
Semin Thromb Hemost; 2013 Jun; 39(4):356-64. PubMed ID: 23504606
[TBL] [Abstract][Full Text] [Related]
4. Regulation of plasminogen activation, matrix metalloproteinases and urokinase-type plasminogen activator-mediated extracellular matrix degradation in human osteosarcoma cell line MG63 by interleukin-1 alpha.
de Bart AC; Quax PH; Löwik CW; Verheijen JH
J Bone Miner Res; 1995 Sep; 10(9):1374-84. PubMed ID: 7502710
[TBL] [Abstract][Full Text] [Related]
5. Insights in vessel development and vascular disorders using targeted inactivation and transfer of vascular endothelial growth factor, the tissue factor receptor, and the plasminogen system.
Carmeliet P; Moons L; Dewerchin M; Mackman N; Luther T; Breier G; Ploplis V; Müller M; Nagy A; Plow E; Gerard R; Edgington T; Risau W; Collen D
Ann N Y Acad Sci; 1997 Apr; 811():191-206. PubMed ID: 9186598
[TBL] [Abstract][Full Text] [Related]
6. The pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of monoclonal antibodies as PAI-1 inhibitors.
Gils A
Verh K Acad Geneeskd Belg; 2006; 68(3):179-98. PubMed ID: 16796017
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical demonstration of the plasminogen activator system in human gingival tissues and gingival fibroblasts.
Xiao Y; Bunn CL; Bartold PM
J Periodontal Res; 1998 Jan; 33(1):17-26. PubMed ID: 9524317
[TBL] [Abstract][Full Text] [Related]
8. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
Ronday HK; Smits HH; Van Muijen GN; Pruszczynski MS; Dolhain RJ; Van Langelaan EJ; Breedveld FC; Verheijen JH
Br J Rheumatol; 1996 May; 35(5):416-23. PubMed ID: 8646430
[TBL] [Abstract][Full Text] [Related]
9. The plasminogen activation system in skeletal muscle regeneration: antagonistic roles of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1).
Suelves M; Vidal B; Ruiz V; Baeza-Raja B; Diaz-Ramos A; Cuartas I; Lluis F; Parra M; Jardi M; Lopez-Alemany R; Serrano AL; Munoz-Canoves P
Front Biosci; 2005 Sep; 10():2978-85. PubMed ID: 15970552
[TBL] [Abstract][Full Text] [Related]
10. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis.
Pepper MS
Arterioscler Thromb Vasc Biol; 2001 Jul; 21(7):1104-17. PubMed ID: 11451738
[TBL] [Abstract][Full Text] [Related]
11. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.
Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618
[TBL] [Abstract][Full Text] [Related]
12. Differential endocytosis of tissue plasminogen activator by serpins PAI-1 and PAI-2 on human peripheral blood monocytes.
Lee JA; Croucher DR; Ranson M
Thromb Haemost; 2010 Dec; 104(6):1133-42. PubMed ID: 20838737
[TBL] [Abstract][Full Text] [Related]
13. Determination of metalloproteinases, plasminogen-activators and their inhibitors in the synovial fluids of patients with rheumatoid arthritis during chemical synoviorthesis.
Blaser J; Triebel S; Maasjosthusmann U; Romisch J; Krahl-Mateblowski U; Freudenberg W; Fricke R; Tschesche H
Clin Chim Acta; 1996 Jan; 244(1):17-33. PubMed ID: 8919199
[TBL] [Abstract][Full Text] [Related]
14. Components of the plasminogen activation system in uveal melanoma--a clinico-pathological study.
De Vries TJ; Mooy CM; Van Balken MR; Luyten GP; Quax PH; Verspaget HW; Weidle UH; Ruiter DJ; Van Muijen GN
J Pathol; 1995 Jan; 175(1):59-67. PubMed ID: 7891228
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator and its inhibitor in the experimental corneal wound.
Tervo T; Tervo K; van Setten GB; Virtanen I; Tarkkanen A
Exp Eye Res; 1989 Mar; 48(3):445-9. PubMed ID: 2494049
[TBL] [Abstract][Full Text] [Related]
16. Effects of castration on plasminogen activator activities and plasminogen activator inhibitor type 1 in the rat ventral prostate.
Wilson MJ; Ludowese C; Sinha AA; Estensen RD
Prostate; 1996 Apr; 28(4):239-50. PubMed ID: 8602400
[TBL] [Abstract][Full Text] [Related]
17. The plasminogen-plasminogen activator (PA) system in neuroblastoma: role of PA inhibitor-1 in metastasis.
Sugiura Y; Ma L; Sun B; Shimada H; Laug WE; Seeger RC; DeClerck YA
Cancer Res; 1999 Mar; 59(6):1327-36. PubMed ID: 10096567
[TBL] [Abstract][Full Text] [Related]
18. Localization of urokinase-type plasminogen activator, plasminogen activator inhibitor-1, 2 and plasminogen in colon cancer.
Naitoh H; Eguchi Y; Ueyama H; Kodama M; Hattori T
Jpn J Cancer Res; 1995 Jan; 86(1):48-56. PubMed ID: 7737909
[TBL] [Abstract][Full Text] [Related]
19. Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.
Lijnen HR; Moons L; Beelen V; Carmelie P; Collen D
Thromb Haemost; 1995 Oct; 74(4):1126-31. PubMed ID: 8560424
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of plasminogen activators in human gingival crevicular fluid.
Brown JM; Watanabe K; Cohen RL; Chambers DA
Arch Oral Biol; 1995 Sep; 40(9):839-45. PubMed ID: 8651888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
